Acadia Pharmaceuticals Inc is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders.
|Year||Equity||Revenue||EBITDA||Fin. Res.||Net Inc.||Net Mar.||ROE||Cash||Debt||N.D. / EBITDA||OCF||CAPEX||FCF||Free||Div.|
The values above are represented in USD and the scale is in millions—10.000 is the equivalent of 10 billions. L inside the table means Loss.